TD Cowen lowered the firm’s price target on Option Care Health (OPCH) to $27 from $30 and keeps a Hold rating on the shares. The firm updated its model following Q3 results as Stelara uncertainty suggests a more cautious 2026 outlook.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health’s Earnings Call Highlights Growth and Challenges
- Option Care Health price target lowered to $36 from $38 at Citizens JMP
- Option Care Health Reports Strong Q3 2025 Results
- Option Care Health: Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Option Care Health reports Q3 adjusted EPS 45c, consensus 43c